http://orcid.org/0000-0002-1243-2463
Citations (40)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
James P Franciosi, Edward B Mougey, Evan S Dellon, Carolina Gutierrez-Junquera, Sonia Fernandez-Fernandez, Rajitha D Venkatesh & Sandeep K Gupta. (2022) Proton Pump Inhibitor Therapy for Eosinophilic Esophagitis: History, Mechanisms, Efficacy, and Future Directions. Journal of Asthma and Allergy 15, pages 281-302.
Read now
Read now
Ahmed Al-Marhabi, Ahmed Hashem, Bader Faiyaz Zuberi, Charles Onyekwere, Imran Lodhi, Mohamed Mounir, Saad Alkhowaiter, Sameer Al Awadhi, Vasudevan G. Naidoo & Yasser Hamada. (2022) The views of African and Middle Eastern Gastroenterologists on the management of mild-to-moderate, non-erosive gastro-esophageal reflux disease (GERD). Expert Review of Gastroenterology & Hepatology 16:3, pages 217-233.
Read now
Read now
Xiao-Yu Zhang, Tao Li, Haibing Wu, Yun Ling, Zhi-Ping Qian & Liang Chen. (2021) Analysis of the Effect of Proton-Pump Inhibitors on the Course of COVID-19. Journal of Inflammation Research 14, pages 287-298.
Read now
Read now
Aitor Lanas-Gimeno, Gonzalo Hijos & Ángel Lanas. (2019) Proton pump inhibitors, adverse events and increased risk of mortality. Expert Opinion on Drug Safety 18:11, pages 1043-1053.
Read now
Read now
Articles from other publishers (36)
Heli Järvinen, Anna-Maija Tolppanen & Sirpa Hartikainen. (2023) Risk factors of pneumonia in persons with and without Alzheimer’s disease: a matched cohort study. BMC Geriatrics 23:1.
Crossref
Crossref
Julian Legg, Jamie-Leigh Allen, Morag Andrew, Charlotte Annesley, Michelle Chatwin, Hannah Crawford, Joanna Elverson, Julian Forton, Kate Oulton, Kate Renton, Alison Tavare, Hilary Tedd & A John Simpson. (2023) BTS Clinical Statement on the prevention and management of community-acquired pneumonia in people with learning disability. Thorax 78:Suppl 1, pages s1.1-s31.
Crossref
Crossref
Naina Mohamed Pakkir Maideen. (2023) Adverse Effects Associated with Long-Term Use of Proton Pump Inhibitors. Chonnam Medical Journal 59:2, pages 115.
Crossref
Crossref
Bokyung Kim, Jin-Hyung Jung, Kyungdo Han, Seungkyung Kang, Eunwoo Lee, Hyunsoo Chung, Sang Gyun Kim & Soo-Jeong Cho. (2023) Histamine-2 Receptor Antagonists and Proton Pump Inhibitors Are Associated With Reduced Risk of SARS-CoV-2 Infection Without Comorbidities Including Diabetes, Hypertension, and Dyslipidemia: A Propensity Score-Matched Nationwide Cohort Study. Journal of Korean Medical Science 38:13.
Crossref
Crossref
Xiaoyi Gao, Zi Yi Shao, Noam Grysman & George T Grossberg. (2023) Proton Pump Inhibitor Use and Risk of Dementia in Older Adults: A Systematic Review. US Neurology 19:1, pages 21.
Crossref
Crossref
Dorota Ksiądzyna & Adam Szeląg. (2023) The Proton Pump Inhibitors Use and COVID-19 from Prior to Vaccination Perspective: A Review. Digestive Diseases 41:3, pages 513-521.
Crossref
Crossref
Emily K. Acton, Allison W. Willis & Sean Hennessy. (2022) Core concepts in pharmacoepidemiology: Key biases arising in pharmacoepidemiologic studies. Pharmacoepidemiology and Drug Safety 32:1, pages 9-18.
Crossref
Crossref
S. Bally, J. Cottin, M. C. Gagnieu, J. C. Lega, C. Verstuyft, S. Rheims, G. Lesca, M. Cucherat & Guillaume Grenet. (2022) Publication bias in pharmacogenetics of adverse reaction to antiseizure drugs: An umbrella review and a meta-epidemiological study. PLOS ONE 17:12, pages e0278839.
Crossref
Crossref
T. E. Kugler, I. S. Malovichko, V. B. Gnilitskaya, A. L. Khristulenko & N. F. Yarovaya. (2022) Proton Pump Inhibitors in the COVID-19 Pandemic. The Russian Archives of Internal Medicine 12:4, pages 245-253.
Crossref
Crossref
Shanna C. Trenaman, Austin Harding, Susan K. Bowles, Susan A. Kirkland & Melissa K. Andrew. (2022) A Prescribing Cascade of Proton Pump Inhibitors Following Anticholinergic Medications in Older Adults With Dementia. Frontiers in Pharmacology 13.
Crossref
Crossref
Antonella Laria, Alfredo Maria Lurati, Gaetano Zizzo, Eleonora Zaccara, Daniela Mazzocchi, Katia Angela Re, Mariagrazia Marrazza, Paola Faggioli & Antonino Mazzone. (2022) Interstitial Lung Disease in Rheumatoid Arthritis: A Practical Review. Frontiers in Medicine 9.
Crossref
Crossref
Yun-Han Wang, Henrik Svanström, Viktor Wintzell, Jonas F Ludvigsson & Björn Pasternak. (2022) Association between proton pump inhibitor use and risk of pneumonia in children: nationwide self-controlled case series study in Sweden. BMJ Open 12:4, pages e060771.
Crossref
Crossref
Hong-Bae Kim, Jung-Ha Kim & Bethany J. Wolf. (2021) Acid suppressant use in association with incidence and severe outcomes of COVID-19: a systematic review and meta-analysis. European Journal of Clinical Pharmacology 78:3, pages 383-391.
Crossref
Crossref
Terry Cheuk-Fung Yip, Francis Ka-Leung Chan, Grace Chung-Yan Lui, Vincent Wai-Sun Wong, Henry Lik-Yuen Chan, Sunny Hei Wong, Joyce Wing-Yan Mak, Siew-Chien Ng, David Shu-Cheong Hui & Grace Lai-Hung Wong. (2022) Use of Proton-Pump Inhibitor Is Not Associated with Adverse Clinical Outcomes in COVID-19 Patients: A Territory-Wide Cohort Study. GastroHep 2022, pages 1-13.
Crossref
Crossref
Philip O. Katz, Kerry B. Dunbar, Felice H. Schnoll-Sussman, Katarina B. Greer, Rena Yadlapati & Stuart Jon Spechler. (2022) ACG Clinical Guideline for the Diagnosis and Management of Gastroesophageal Reflux Disease. American Journal of Gastroenterology 117:1, pages 27-56.
Crossref
Crossref
Anjan Dhar, Frances Maw, Helen Jane Dallal & Stephen Attwood. (2022) Side effects of drug treatments for gastro-oesophageal reflux disease: current controversies. Frontline Gastroenterology 13:1, pages 45-49.
Crossref
Crossref
Yoon Duk Hong, Jeroen P. Jansen, John Guerino, Marc L. Berger, William Crown, Wim G. Goettsch, C. Daniel Mullins, Richard J. Willke & Lucinda S. Orsini. (2021) Comparative effectiveness and safety of pharmaceuticals assessed in observational studies compared with randomized controlled trials. BMC Medicine 19:1.
Crossref
Crossref
Grazia Mazzeo, Luigi Aronne, Domenica Francesca Mariniello, Valentino Allocca, Maria Ilaria Palma, Francesco Saverio Cerqua, Carlo Iadevaia, Adriano Costigliola, Roberto Parrella, Andrea Bianco & Vanvitelli/Monaldi COVID Group. (2021) Which impact for proton pump inhibitors in SARS-COV-2 pneumonia. Monaldi Archives for Chest Disease.
Crossref
Crossref
Lucien Roulet. (2021) A nationwide cohort study with propensity score matching. Gut 70:9, pages 1802-1803.
Crossref
Crossref
Elizabeth M. Salvo, Nicole C. Ferko, Sarah B. Cash, Ailish Gonzalez & Peter J. Kahrilas. (2021) Umbrella review of 42 systematic reviews with meta‐analyses: the safety of proton pump inhibitors. Alimentary Pharmacology & Therapeutics 54:2, pages 129-143.
Crossref
Crossref
Kun-Siang Huang, Bo-Lin Pan, Wei-An Lai, Pin-Jie Bin, Yao-Hsu Yang & Chia-Pei Chou. (2021) Could prokinetic agents protect long-term nasogastric tube-dependent patients from being hospitalized for pneumonia? A nationwide population-based case-crossover study. PLOS ONE 16:4, pages e0249645.
Crossref
Crossref
Jan Homolak, Ivan Kodvanj & Vladimir Trkulja. (2021) An Additional Perspective on Proton Pump Inhibitors as Risk Factors for COVID-19. Clinical Drug Investigation 41:3, pages 287-289.
Crossref
Crossref
Seung Won Lee, Eun Kyo Ha, Abdullah Özgür Yeniova, Sung Yong Moon, So Young Kim, Hyun Yong Koh, Jee Myung Yang, Su Jin Jeong, Sun Joon Moon, Joo Young Cho, In Kyung Yoo & Dong Keon Yon. (2021) Severe clinical outcomes of COVID-19 associated with proton pump inhibitors: a nationwide cohort study with propensity score matching. Gut 70:1, pages 76-84.
Crossref
Crossref
V. T. Ivashkin, I. V. Maev, A. S. Trukhmanov, A. A. Sheptulin, V. I. Simanenkov, T. L. Lapina, I. B. Khlynov, N. N. Dekhnich, O. D. Lopina, O. P. Alekseeva, N. V. Korochanskaya, M. F. Osipenko, P. V. Pavlov, S. S. Pirogov, G. N. Tarasova, Yu. P. Uspenskiy, D. N. Andreev & D. E. Rumyantseva. (2020) Deprescribing and Optimal Selection of Proton Pump Inhibitors (Contributions of the 26th United Russian Gastroenterology Week). Russian Journal of Gastroenterology, Hepatology, Coloproctology 30:6, pages 7-18.
Crossref
Crossref
Timotius Ivan Hariyanto, Ignatius Bima Prasetya & Andree Kurniawan. (2020) Proton pump inhibitor use is associated with increased risk of severity and mortality from coronavirus disease 2019 (COVID-19) infection. Digestive and Liver Disease 52:12, pages 1410-1412.
Crossref
Crossref
Sara Aleraij, Sultan Alhowti, Mazen Ferwana, Imad Abdulmajeed & Ibrahim Mohsen Mutawwam. (2020) Effect of proton pump inhibitors on bone mineral density: A systematic review and meta-analysis of observational studies. Bone Reports 13, pages 100732.
Crossref
Crossref
Tae Jun Kim & Hyuk Lee. (2020) Clinical Significance of Changes in Gut Microbiome Associated with Use of Proton Pump Inhibitors. The Korean Journal of Helicobacter and Upper Gastrointestinal Research 20:3, pages 196-203.
Crossref
Crossref
Edoardo G. Giannini, Mattia Crespi, Afscin Djahandideh, Maria Giulia Demarzo, Alessandro Moscatelli, Giorgia Bodini, Manuele Furnari, Elisa Marabotto, Maria Corina Plaz Torres, Patrizia Zentilin & Vincenzo Savarino. (2020) Appropriateness of proton pump inhibitors treatment in clinical practice: Prospective evaluation in outpatients and perspective assessment of drug optimisation. Digestive and Liver Disease 52:8, pages 862-868.
Crossref
Crossref
Vincenzo Savarino, Elisa Marabotto, Manuele Furnari, Fabiana Zingone, Patrizia Zentilin & Edoardo Savarino. (2020) Latest insights into the hot question of proton pump inhibitor safety – a narrative review. Digestive and Liver Disease 52:8, pages 842-852.
Crossref
Crossref
Jerome R. Lechien, Jonathan M. Bock, Thomas L. Carroll & Lee M. Akst. (2020) Is empirical treatment a reasonable strategy for laryngopharyngeal reflux? A contemporary review. Clinical Otolaryngology 45:4, pages 450-458.
Crossref
Crossref
Edoardo Vincenzo Savarino, Paola Iovino, Antonella Santonicola, Matteo Ghisa, Giorgio Laserra, Brigida Barberio, Daria Maniero, Greta Lorenzon, Carolina Ciacci, Vincenzo Savarino & Fabiana Zingone. (2020) Clinical and Psychological Impact of COVID-19 Infection in Adult Patients with Eosinophilic Gastrointestinal Disorders during the SARS-CoV-2 Outbreak. Journal of Clinical Medicine 9:6, pages 2011.
Crossref
Crossref
M Ashworth Dirac, Saeid Safiri, Derrick Tsoi, Rufus Adesoji Adedoyin, Ashkan Afshin, Narjes Akhlaghi, Fares Alahdab, Abdulaziz M Almulhim, Saeed Amini, Floriane Ausloos, Umar Bacha, Maciej Banach, Akshaya Srikanth Bhagavathula, Ali Bijani, Antonio Biondi, Antonio Maria Borzì, Danny Colombara, Kathleen Elizabeth Corey, Baye Dagnew, Ahmad Daryani, Dragos Virgil Davitoiu, Feleke Mekonnen Demeke, Gebre Teklemariam Demoz, Huyen Phuc Do, Arash Etemadi, Farshad Farzadfar, Florian Fischer, Abadi Kahsu Gebre, Hadush Gebremariam, Berhe Gebremichael, Ahmad Ghashghaee, Uday C Ghoshal, Samer Hamidi, Milad Hasankhani, Shoaib Hassan, Simon I Hay, Chi Linh Hoang, Michael K Hole, Kevin S Ikuta, Olayinka Stephen Ilesanmi, Seyed Sina Naghibi Irvani, Spencer L James, Farahnaz Joukar, Ali Kabir, Hagazi Gebremedhin Kassaye, Taras Kavetskyy, Andre Pascal Kengne, Rovshan Khalilov, Muhammad U Khan, Ejaz Ahmad Khan, Maseer Khan, Amir Khater, Ruth W Kimokoti, Ai Koyanagi, Ana-Laura Manda, Dhruv Mehta, Varshil Mehta, Tuomo J Meretoja, Tomislav Mestrovic, Erkin M Mirrakhimov, Prasanna Mithra, Abdollah Mohammadian-Hafshejani, Milad Mohammadoo-Khorasani, Ali H Mokdad, Maryam Moossavi, Ghobad Moradi, Ghulam Mustafa, Mukhammad David Naimzada, Siavosh Nasseri-Moghaddam, Javad Nazari, Ionut Negoi, Cuong Tat Nguyen, Huong Lan Thi Nguyen, Molly R Nixon, Solomon Olum, Akram Pourshams, Hossein Poustchi, Mohammad Rabiee, Navid Rabiee, Alireza Rafiei, Salman Rawaf, David Laith Rawaf, Nicholas L S Roberts, Gholamreza Roshandel, Saeed Safari, Hamideh Salimzadeh, Benn Sartorius, Arash Sarveazad, Sadaf G Sepanlou, Amrollah Sharifi, Amin Soheili, Hafiz Ansar Rasul Suleria, Degena Bahrey Tadesse, Freweini Gebrearegay G Tela, Berhe Etsay Tesfay, Bhaskar Thakur, Bach Xuan Tran, Marco Vacante, Parviz Vahedi, Yousef Veisani, Theo Vos, Kia Vosoughi, Andrea Werdecker, Adam Belay Wondmieneh, Yordanos Gizachew Yeshitila, Mohammad Zamani, Kaleab Alemayehu Zewdie, Zhi-Jiang Zhang, Reza Malekzadeh & Mohsen Naghavi. (2020) The global, regional, and national burden of gastro-oesophageal reflux disease in 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. The Lancet Gastroenterology & Hepatology 5:6, pages 561-581.
Crossref
Crossref
Bryant R. England & Daniel Hershberger. (2020) Management issues in rheumatoid arthritis-associated interstitial lung disease. Current Opinion in Rheumatology 32:3, pages 255-263.
Crossref
Crossref
Martinsen, Fossmark & Waldum. (2019) The Phylogeny and Biological Function of Gastric Juice—Microbiological Consequences of Removing Gastric Acid. International Journal of Molecular Sciences 20:23, pages 6031.
Crossref
Crossref
Kate N. Wang, J. Simon Bell, Edwin C. K. Tan, Julia F. M. Gilmartin-Thomas, Michael J. Dooley & Jenni Ilomäki. (2019) Proton Pump Inhibitors and Infection-Related Hospitalizations Among Residents of Long-Term Care Facilities: A Case–Control Study. Drugs & Aging 36:11, pages 1027-1034.
Crossref
Crossref
Thomas Frieling. (2019) Gastroösophageale RefluxkrankheitGastroesophageal Reflux Disease. Journal für Gastroenterologische und Hepatologische Erkrankungen 17:2, pages 28-37.
Crossref
Crossref